ENDOR AG/ DE0005491666 /
| 15/11/2024 15:44:57 | Chg. -0.001 | Volume | Bid17:30:00 | Ask17:30:00 | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 0.004EUR | -11.11% | 1,600 Turnover: 6.400 |
-Bid Size: - | -Ask Size: - | 61,992EUR | - | 0.02 |
GlobeNewswire
28/03
CIO Leadership: Celebrating Charlie Feld and Other Recipients of HMG Strategy’s Global Leadership In...
GlobeNewswire
01/05/2020
SHAREHOLDER ALERT: WeissLaw LLP Reminds NTGN, SBBX, QUMU, and MSBF Shareholders About Its Ongoing In...
GlobeNewswire
28/04/2020
Rigrodsky & Long, P.A. Files Class Action Suit Against Neon Therapeutics, Inc.
GlobeNewswire
24/04/2020
SHAREHOLDER ALERT: WeissLaw LLP Reminds NTGN, SBBX, QUMU, and MSBF Shareholders About Its Ongoing In...
GlobeNewswire
17/04/2020
SHAREHOLDER ALERT: WeissLaw LLP Reminds NTGN, MSBF, QUMU and SBBX Shareholders About Its Ongoing Inv...
GlobeNewswire
02/03/2020
Neon Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business ...
GlobeNewswire
16/01/2020
BioNTech to acquire Neon to strengthen global leadership position in T cell therapies
GlobeNewswire
16/01/2020
BioNTech to acquire Neon to strengthen global leadership position in T cell therapies
